Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -109.43% is 31% above its 5-year average of -158.99%, near the high end of its 5-year range (-725.29%–-55.78%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.68% above its 12-month average of -246.93%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -109.43%.
RETURN ON INVESTED CAPITAL (ROIC)
-109.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-246.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-208.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-158.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.68%
CURRENT VS 3Y AVG
+47.52%
CURRENT VS 5Y AVG
+31.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.25%
median of 439 covered companies
CURRENT VS SECTOR MEDIAN
-301.59%
vs the sector median at left
Cognition Therapeutics, Inc.
Market Cap
$83.96M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-246.93%
3Y Avg
-208.53%
5Y Avg
-158.99%
Market Cap
$84.00M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$83.49M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.70M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$84.75M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$86.69M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$81.22M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-42.77%
3Y Avg
-39.33%
5Y Avg
-39.33%
Market Cap
$87.86M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
Market Cap
$88.21M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cognition Therapeutics, Inc. (CGTX) | $83.96M | -109.43% | -246.93% | -208.53% | -158.99% |
| Humacyte, Inc. (HUMA)vs › | $84.00M | -90.27% | -103.33% | -85.38% | -72.83% |
| Conexeu Sciences Inc. (CNXU)vs › | $83.49M | N/A | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | -100.35% | -639.99% | -358.78% | -266.51% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | -88.28% | -61.59% | -48.92% | -67.61% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 12.79% | 17.38% | -11.40% | -8.36% |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | -88.72% | -42.77% | -39.33% | -39.33% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | -159.30% | -82.85% | -66.58% | -50.22% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 8.16% | 0.11% | -4.79% | -3.69% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | -836.58% | -213.85% | -158.30% | -121.35% |
ROIC
-109.4%
ROE
-50.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -109.43% |
| 2026-03-31 | -141.48% |
| 2025-12-31 | -136.92% |
| 2025-09-30 | -121.52% |
| 2025-06-30 | -725.29% |
| 2025-03-31 | -421.99% |
| 2024-12-31 | -278.59% |
| 2024-09-30 | -392.85% |
| 2024-06-30 | -248.43% |
| 2024-03-31 | -187.97% |
| 2023-12-31 | -198.62% |
| 2023-09-30 | -146.78% |
| 2023-06-30 | -117.79% |
| 2023-03-31 | -111.61% |
| 2022-12-31 | -100.66% |
| 2022-09-30 | -111.14% |
| 2022-06-30 | -83.32% |
| 2022-03-31 | -62.54% |
| 2021-12-31 | -55.78% |
| 2021-09-30 | -233.34% |
| 2021-06-30 | -182.09% |
| 2021-03-31 | -148.67% |
| 2020-12-31 | -449.91% |
